Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Letter to Congress about Medicaid Coverage of Genetic and Genomic Testing
-
Group Sign-on Letter to Congress (Senate) Requesting FY 2022 Appropriations for Newborn Screening Programs
-
Group Sign-on Letter to Congress (House) Requesting FY 2022 Appropriations for Newborn Screening Programs
-
Group Sign-on Letter to Congress Expressing Concerns about Patent Eligibility Reform Stakeholder Discussions
-
Group Sign-on Letter to Congress (Senate) Requesting FY 2021 Appropriations for Newborn Screening Programs
-
Group Sign-on Letter to Congress (House) Requesting FY 2021 Appropriations for Newborn Screening Programs
-
Group Sign-on Letter to HHS Supporting Continuation of the ACHDNC
-
ACMG-ASHG Joint Congressional Briefing on the Undiagnosed Diseases Network
-
ACMG & ASHG Presidents’ Sign-on Letter to Congress Concerning Patent Eligibility Reform
-
Group Letter to Congress Supporting the Newborn Screening Saves Lives Reauthorization Act (NBSSLRA) of 2019